Cyclacel Pharmaceuticals, Inc. (CYCC)

Stock Price Forecast

There is currently no analyst price target forecast available for Cyclacel Pharmaceuticals.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Cyclacel Pharmaceuticals.

Recommendation Trends

Rating	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24	May '24
Strong Buy	1	1	1	1	1	0
Buy	1	1	1	1	1	0
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $336 → $176	Strong Buy	Maintains	$336 → $176	+48,053.21%	May 3, 2024
Kemp Dolliver Brookline Capital	Brookline Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Dec 19, 2023
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $256 → $336	Strong Buy	Maintains	$256 → $336	+91,828.86%	Dec 19, 2023
Jeff Jones Oppenheimer	Oppenheimer	Buy Maintains $1,920	Buy	Maintains	$1,920	+525,207.80%	May 25, 2023
Jeff Jones Oppenheimer	Oppenheimer	Buy Maintains $2,400 → $1,920	Buy	Maintains	$2,400 → $1,920	+525,207.80%	Mar 7, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

102.00K

Increased by 137.21%

from 43.00K

Revenue Next Year

102.00K

from 102.00K

EPS This Year

-1.20

from -33.50

EPS Next Year

-1.14

from -1.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	420.00K	43.00K	102.00K	102.00K	82.19M
Revenue Growth	-	-	-	-	-89.76%	137.21%	-	80,482.35%
EPS	-820.80	-501.67	-456.28	-427.94	-33.50	-1.20	-1.14	3.74
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	0.10
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	105,000	105,000	84.6M
Avg	102,000	102,000	82.2M
Low	98,000	98,000	79.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	144.2%	2.9%	82,852.0%
Avg	137.2%	-	80,482.4%
Low	127.9%	-3.9%	77,321.6%

EPS Forecast

EPS	2025	2026	2027
High	-1.24	-1.18	3.85
Avg	-1.20	-1.14	3.74
Low	-1.16	-1.10	3.60

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.